Alyaa Al-Mughairy: First Pediatric Case of Successful DOAC Treatment in a Clinical Setting
Alyaa Al-Mughairy, Pediatric Hematology Oncology Senior Consultant at Ministry of Health Oman,and National Oncology Centre at Royal Hospital, shared a post on LinkedIn:
“We had an interesting discussion this morning presented by one of our enthusiastic pediatrics Omsb resident Dr Shaima Al suror, focusing on the diagnosis and management of a complex challenging case of massive pediatric Venous Thromboembolism (VTE).
The case required an intensive, multi-modal approach involving multiple sessions of thrombolysis and thrombectomy later successfully transitioned to dual anticoagulation including direct oral anticoagulation (DOAC).
This represents the first pediatric case in our clinical setting to be successfully treated with DOAC.
We remain dedicated to advancing clinical management to ensure our patients receive the highest standard of care.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering